Shin-Ichi Miyatake Shinji Kawabata Ryo Hiramatsu Motomasa Furuse Toshihiko Kuroiwa Minoru Suzuki
10.1186/1748-717X-9-6
Radiat Oncol
2014 Jan 6;9:6.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24387301/
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents / therapeutic use Boron Neutron Capture Therapy Brain Neoplasms / therapy Glioma / therapy Neoplasm Recurrence, Local / therapy
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents / therapeutic use Boron Neutron Capture Therapy Brain Neoplasms / therapy Glioma / therapy Neoplasm Recurrence, Local / therapy Case Reports Research Support, Non-U.S. Gov't Adult Bevacizumab Brain Neoplasms / mortality Chemoradiotherapy Female Glioma / mortality Humans Male Middle Aged Neoplasm Recurrence, Local / mortality Survival Antibodies, Monoclonal, Humanized Antineoplastic Agents Bevacizumab
PMC3923505
24387301
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
2014